Skip to main content
Premium Trial:

Request an Annual Quote

UK University Taps Dotmatics ELN to Support Drug Discovery Research

Premium

Dotmatics said this week that University of Sussex has added Studies Notebook, the company's web-based electronic laboratory notebook, to its existing Dotmatics data management platform.

The software Dotmatics provides supports ongoing projects from the university's translational drug discovery group in areas such as hit identification and lead optimization. Simon Ward, a professor of medicinal chemistry and co-director of the group, said that the company's products enable "us to work very effectively and to process and analyze data in a highly efficient manner."

John Atack, a professor of molecular pharmacology and group co-director, described Dotmatics' platform as "a fully optimized and perfectly integrated addition to our existing chemoinformatics platform." It enables "us to access all of our data in a single web-based platform and allows our scientists to streamline their data entry, triage, and analysis," he said.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.